Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2025-12-24 @ 2:35 PM
NCT ID:
NCT02465359
Eligibility Criteria:
Inclusion Criteria:
To qualify, a patient must have CIDP and persistence of significant symptoms (having 2 or more of the following):
* Weakness in any limb,
* Motor fatigue significant to interfere with activities of daily living (ADL) or work,
* Paresthesia of sufficient severity to require a medication,
* Sensory impairment,
* Walking impairment,
AND requires IVIG to control symptoms.
Exclusion Criteria:
1. Thrombocytopenia or other bleeding disorders,
2. Anticoagulation therapy,
3. Severe or anaphylactoid reactions to IVIG,
4. Cancer,
5. Pregnancy,
6. Breast-feeding,
7. Renal insufficiency or failure,
8. Congestive heart failure,
9. Psychiatric illness.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02465359
Study Brief:
Protocol Section:
NCT02465359